[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 14, Issue 2 (March-2022 2022) ::
IJBC 2022, 14(2): 68-74 Back to browse issues page
Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer
Masoumeh Mohammadi, Mehdi Hedayati *
Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (190 Views)
Obesity is an important public health problem worldwide. Epidemiological studies have demonstrated that obesity is associated with an increased risk of several cancer types. Also, obesity is associated with an increase in cancer mortality. Biological mechanisms and the relationship between obesity and cancer are complex and not well understood. Studies on the role of adiposederived factors in cancer development may be the mechanistic link between obesity and cancer risks. Visfatin or pre-B cell enhancing factor (PBEF) or nicotin-amide-phosphoribosyl-transferase (Nampt) is an important hormone protein that is mainly produced by adipose tissue, and has three major functions: growth factor, cytokine, and nicotinamide phosphoribosyltransferase, therefore, increasing of visfatin has several effects. Recently, studies have shown that over-expression of visfatin is important in the carcinogenesis of several types of cancers. This review aimed to summarize findings from both experimental and epidemiological studies investigating the association between visfatin levels and cancer risk.
Keywords: Visfatin, gstric cancer, breast cancer, prostate cancer, colorectal cancer, leukemia, thyroid cancer.
Full-Text [PDF 263 kb]   (85 Downloads)    
: Review Article | Subject: Genetics
Received: 2021/12/6 | Accepted: 2022/06/4 | Published: 2022/06/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi M, hedayati M. Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer. IJBC. 2022; 14 (2) :68-74
URL: http://ijbc.ir/article-1-1205-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 2 (March-2022 2022) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4457